Copyright Reports & Markets. All rights reserved.

Global and United States Ocular Genetic Diagnostic Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Ocular Genetic Diagnostic Revenue in Ocular Genetic Diagnostic Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Ocular Genetic Diagnostic Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Ocular Genetic Diagnostic Market Size for the Year 2017-2028
      • 1.2.2 Global Ocular Genetic Diagnostic Market Size for the Year 2017-2028
    • 1.3 Ocular Genetic Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Ocular Genetic Diagnostic in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Ocular Genetic Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Ocular Genetic Diagnostic Market Dynamics
      • 1.4.1 Ocular Genetic Diagnostic Industry Trends
      • 1.4.2 Ocular Genetic Diagnostic Market Drivers
      • 1.4.3 Ocular Genetic Diagnostic Market Challenges
      • 1.4.4 Ocular Genetic Diagnostic Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Ocular Genetic Diagnostic by Type

    • 2.1 Ocular Genetic Diagnostic Market Segment by Type
      • 2.1.1 Next-generation Sequencing (NGS)
      • 2.1.2 Multiplex Ligation-Dependent Probe Amplification (MLPA)
      • 2.1.3 Fragment Analysis PCR for Repeat Expansion Analysis
    • 2.2 Global Ocular Genetic Diagnostic Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Ocular Genetic Diagnostic Market Size by Type (2017-2028)
    • 2.4 United States Ocular Genetic Diagnostic Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Ocular Genetic Diagnostic Market Size by Type (2017-2028)

    3 Ocular Genetic Diagnostic by Application

    • 3.1 Ocular Genetic Diagnostic Market Segment by Application
      • 3.1.1 Hospitals
      • 3.1.2 Diagnostic Laboratories
      • 3.1.3 Academic and Research Centers
      • 3.1.4 Others
    • 3.2 Global Ocular Genetic Diagnostic Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Ocular Genetic Diagnostic Market Size by Application (2017-2028)
    • 3.4 United States Ocular Genetic Diagnostic Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Ocular Genetic Diagnostic Market Size by Application (2017-2028)

    4 Global Ocular Genetic Diagnostic Competitor Landscape by Company

    • 4.1 Global Ocular Genetic Diagnostic Market Size by Company
      • 4.1.1 Top Global Ocular Genetic Diagnostic Companies Ranked by Revenue (2021)
      • 4.1.2 Global Ocular Genetic Diagnostic Revenue by Player (2017-2022)
    • 4.2 Global Ocular Genetic Diagnostic Concentration Ratio (CR)
      • 4.2.1 Ocular Genetic Diagnostic Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Ocular Genetic Diagnostic in 2021
      • 4.2.3 Global Ocular Genetic Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Ocular Genetic Diagnostic Headquarters, Revenue in Ocular Genetic Diagnostic Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Ocular Genetic Diagnostic Headquarters and Area Served
      • 4.3.2 Global Ocular Genetic Diagnostic Companies Revenue in Ocular Genetic Diagnostic Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Ocular Genetic Diagnostic Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Ocular Genetic Diagnostic Market Size by Company
      • 4.5.1 Top Ocular Genetic Diagnostic Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Ocular Genetic Diagnostic Revenue by Players (2020, 2021 & 2022)

    5 Global Ocular Genetic Diagnostic Market Size by Region

    • 5.1 Global Ocular Genetic Diagnostic Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Ocular Genetic Diagnostic Market Size by Region (2017-2028)
      • 5.2.1 Global Ocular Genetic Diagnostic Market Size by Region: 2017-2022
      • 5.2.2 Global Ocular Genetic Diagnostic Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Ocular Genetic Diagnostic Market Size YoY Growth 2017-2028
      • 6.1.2 North America Ocular Genetic Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Ocular Genetic Diagnostic Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Ocular Genetic Diagnostic Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Ocular Genetic Diagnostic Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Ocular Genetic Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Ocular Genetic Diagnostic Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Ocular Genetic Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Ocular Genetic Diagnostic Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Ocular Genetic Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Quest Diagnostics
      • 7.1.1 Quest Diagnostics Company Details
      • 7.1.2 Quest Diagnostics Business Overview
      • 7.1.3 Quest Diagnostics Ocular Genetic Diagnostic Introduction
      • 7.1.4 Quest Diagnostics Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.1.5 Quest Diagnostics Recent Development
    • 7.2 Columbia ophthalmology
      • 7.2.1 Columbia ophthalmology Company Details
      • 7.2.2 Columbia ophthalmology Business Overview
      • 7.2.3 Columbia ophthalmology Ocular Genetic Diagnostic Introduction
      • 7.2.4 Columbia ophthalmology Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.2.5 Columbia ophthalmology Recent Development
    • 7.3 Centogene
      • 7.3.1 Centogene Company Details
      • 7.3.2 Centogene Business Overview
      • 7.3.3 Centogene Ocular Genetic Diagnostic Introduction
      • 7.3.4 Centogene Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.3.5 Centogene Recent Development
    • 7.4 DBGen
      • 7.4.1 DBGen Company Details
      • 7.4.2 DBGen Business Overview
      • 7.4.3 DBGen Ocular Genetic Diagnostic Introduction
      • 7.4.4 DBGen Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.4.5 DBGen Recent Development
    • 7.5 Medgenome
      • 7.5.1 Medgenome Company Details
      • 7.5.2 Medgenome Business Overview
      • 7.5.3 Medgenome Ocular Genetic Diagnostic Introduction
      • 7.5.4 Medgenome Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.5.5 Medgenome Recent Development
    • 7.6 Sankara Nethralaya
      • 7.6.1 Sankara Nethralaya Company Details
      • 7.6.2 Sankara Nethralaya Business Overview
      • 7.6.3 Sankara Nethralaya Ocular Genetic Diagnostic Introduction
      • 7.6.4 Sankara Nethralaya Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.6.5 Sankara Nethralaya Recent Development
    • 7.7 Fulgent Genetics
      • 7.7.1 Fulgent Genetics Company Details
      • 7.7.2 Fulgent Genetics Business Overview
      • 7.7.3 Fulgent Genetics Ocular Genetic Diagnostic Introduction
      • 7.7.4 Fulgent Genetics Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.7.5 Fulgent Genetics Recent Development
    • 7.8 GeneDx
      • 7.8.1 GeneDx Company Details
      • 7.8.2 GeneDx Business Overview
      • 7.8.3 GeneDx Ocular Genetic Diagnostic Introduction
      • 7.8.4 GeneDx Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.8.5 GeneDx Recent Development
    • 7.9 Devyser
      • 7.9.1 Devyser Company Details
      • 7.9.2 Devyser Business Overview
      • 7.9.3 Devyser Ocular Genetic Diagnostic Introduction
      • 7.9.4 Devyser Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.9.5 Devyser Recent Development
    • 7.10 Invitae Corporation
      • 7.10.1 Invitae Corporation Company Details
      • 7.10.2 Invitae Corporation Business Overview
      • 7.10.3 Invitae Corporation Ocular Genetic Diagnostic Introduction
      • 7.10.4 Invitae Corporation Revenue in Ocular Genetic Diagnostic Business (2017-2022)
      • 7.10.5 Invitae Corporation Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      There are around 5,000 genetic disorders and syndromes that affect the mankind. Of this vast number, at least one third of them are related to eyes. With the recent advancements in molecular genetics and various sequencing methods, a wide array of various hereditary eye diseases have been discovered.
      Market Analysis and Insights: Global and United States Ocular Genetic Diagnostic Market
      This report focuses on global and United States Ocular Genetic Diagnostic market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Ocular Genetic Diagnostic market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Next-generation Sequencing (NGS) accounting for % of the Ocular Genetic Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Ocular Genetic Diagnostic market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Ocular Genetic Diagnostic Scope and Market Size
      Ocular Genetic Diagnostic market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ocular Genetic Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Ocular Genetic Diagnostic market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Ocular Genetic Diagnostic market is segmented into
      Next-generation Sequencing (NGS)
      Multiplex Ligation-Dependent Probe Amplification (MLPA)
      Fragment Analysis PCR for Repeat Expansion Analysis
      Segment by Application, the Ocular Genetic Diagnostic market is segmented into
      Hospitals
      Diagnostic Laboratories
      Academic and Research Centers
      Others
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Ocular Genetic Diagnostic Market Share Analysis
      Ocular Genetic Diagnostic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Ocular Genetic Diagnostic business, the date to enter into the Ocular Genetic Diagnostic market, Revenue in Ocular Genetic Diagnostic Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      Quest Diagnostics
      Columbia ophthalmology
      Centogene
      DBGen
      Medgenome
      Sankara Nethralaya
      Fulgent Genetics
      GeneDx
      Devyser
      Invitae Corporation
      Buy now